336 related articles for article (PubMed ID: 11064829)
1. Diabetic nephropathy in non-insulin dependent diabetes mellitus. Cardiovascular risk factors and antihypertensive treatment.
Nielsen FS
Dan Med Bull; 2000 Sep; 47(4):249-70. PubMed ID: 11064829
[No Abstract] [Full Text] [Related]
2. [Control of arterial pressure in diabetic nephropathy].
Luño J; García de Vinuesa S
Nefrologia; 2001; 21(3):240-5. PubMed ID: 11471304
[No Abstract] [Full Text] [Related]
3. [Hypertension and diabetic nephropathy, a dangerous duo].
Hausberg M; Hohage H; Kosch M
Med Klin (Munich); 2005 Nov; 100(11):729-37; quiz 738-9. PubMed ID: 16328181
[No Abstract] [Full Text] [Related]
4. [Antihypertensive treatment in the type 2 diabetic].
Fournier A
Nephrologie; 2000; 21(4):203-4. PubMed ID: 10976435
[No Abstract] [Full Text] [Related]
5. Predictors of mortality in patients with type 2 diabetes with or without diabetic nephropathy: a follow-up study.
Astrup AS; Nielsen FS; Rossing P; Ali S; Kastrup J; Smidt UM; Parving HH
J Hypertens; 2007 Dec; 25(12):2479-85. PubMed ID: 17984670
[TBL] [Abstract][Full Text] [Related]
6. [Prediction, screening and treatment of renal complications of diabetes].
Marre M; Larger E
Rev Prat; 2001 Oct; 51(16):1769-75. PubMed ID: 11795120
[TBL] [Abstract][Full Text] [Related]
7. Lisinopril improves endothelial dysfunction in hypertensive NIDDM subjects with diabetic nephropathy.
Nielsen FS; Rossing P; Gall MA; Smidt UM; Chen JW; Sato A; Parving HH
Scand J Clin Lab Invest; 1997 Aug; 57(5):427-34. PubMed ID: 9279969
[TBL] [Abstract][Full Text] [Related]
8. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
Vogt L; Kocks MJ; Laverman GD; Navis G
Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
[TBL] [Abstract][Full Text] [Related]
9. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
[TBL] [Abstract][Full Text] [Related]
10. Masked hypertension in type 2 diabetes mellitus. Relationship with left-ventricular structure and function.
Marchesi C; Maresca AM; Solbiati F; Franzetti I; Laurita E; Nicolini E; Gianni M; Guasti L; Marnini P; Venco A; Grandi AM
Am J Hypertens; 2007 Oct; 20(10):1079-84. PubMed ID: 17903691
[TBL] [Abstract][Full Text] [Related]
11. Diabetic nephropathy: implications for renal and cardiovascular outcomes.
Folan LA; Tuttle KR
Minerva Med; 2004 Oct; 95(5):385-94. PubMed ID: 15467514
[TBL] [Abstract][Full Text] [Related]
12. [Type 2 diabetes and cardiovascular risk: lessons from therapeutic trials].
Lièvre M
Rev Prat; 2001 Oct; 51(16):1793-9. PubMed ID: 11795124
[TBL] [Abstract][Full Text] [Related]
13. Microalbuminuria: a common, independent cardiovascular risk factor, especially but not exclusively in type 2 diabetes.
Donnelly R; Yeung JM; Manning G
J Hypertens Suppl; 2003 Mar; 21(1):S7-12. PubMed ID: 12769161
[TBL] [Abstract][Full Text] [Related]
14. When to treat the hypertensive diabetic patient.
Fuller JH
J Diabetes Complications; 1996; 10(3):144-5. PubMed ID: 8807461
[No Abstract] [Full Text] [Related]
15. Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive Type 2 diabetic patients with microalbuminuria: DIAL study (diabete, ipertensione, albuminuria, lercanidipina).
Dalla Vestra M; Pozza G; Mosca A; Grazioli V; Lapolla A; Fioretto P; Crepaldi G
Diabetes Nutr Metab; 2004 Oct; 17(5):259-66. PubMed ID: 16295047
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic controversies in hypertension management: angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers for diabetic nephropathy? A case for ACE inhibitors.
Crook ED; Preddie DC
Ethn Dis; 2002; 12(4):S3-49-52. PubMed ID: 12477155
[TBL] [Abstract][Full Text] [Related]
17. Morning home blood pressure may be a significant marker of nephropathy in Japanese patients with type 2 diabetes: ADVANCED-J study 1.
Tanaka Y; Daida H; Imai Y; Miyauchi K; Sato Y; Hiwatari M; Kitagawa A; Kishimoto J; Yamazaki T; Kawamori R
Hypertens Res; 2009 Sep; 32(9):770-4. PubMed ID: 19557003
[TBL] [Abstract][Full Text] [Related]
18. Renal function preservation in type 2 diabetes mellitus patients with early nephropathy: a comparative prospective cohort study between primary health care doctors and a nephrologist.
Martínez-Ramírez HR; Jalomo-Martínez B; Cortés-Sanabria L; Rojas-Campos E; Barragán G; Alfaro G; Cueto-Manzano AM
Am J Kidney Dis; 2006 Jan; 47(1):78-87. PubMed ID: 16377388
[TBL] [Abstract][Full Text] [Related]
19. Is treatment of hypertension with acetylcholine esterase inhibitors (ACEIs) superior to other antihypertensives in preventing significant cardiovascular events and death in patients with type 2 diabetes?
McConaghy JR
J Fam Pract; 2000 Nov; 49(11):980. PubMed ID: 11093559
[No Abstract] [Full Text] [Related]
20. [Diabetic nephropathy. Are the blood pressure values set too low?].
Zidek W
MMW Fortschr Med; 2003 Dec; 145(49):14. PubMed ID: 14963985
[No Abstract] [Full Text] [Related]
[Next] [New Search]
